Skip to main content

Table 1 Characteristics of CLL subjects

From: GIFT4 fusokine converts leukemic B cells into immune helper cells

CLL subject number Gender Age CD5+CD19+ CLL cells
in PBMC (%)
1 M 78 93.2
2 F 74 87.6
3 M 64 93.8
4 M 57 81.6
5 M 72 86.1
6 M 38 84.2
7 F 56 95.6
8 F 75 82.6
9 F 52 81.0
10 F 76 87.4
11 M 54 94.7
12 M 62 86.0